A pharmaceutical excipient that promotes tablet disintegration in the gastrointestinal tract for drug release.
Disintegrants are essential pharmaceutical excipients incorporated into tablet formulations to facilitate rapid breakdown of the compressed tablet into smaller particles or granules upon contact with gastrointestinal fluids. This mechanical disruption increases surface area, accelerating drug dissolution and bioavailability. They function through mechanisms like swelling, wicking, deformation recovery, or gas production to overcome tablet bonding forces.
诱因 → 失效模式 → 工程缓解
不是客户评论，也不是实时热度。以下维度用于前期 RFQ 准备和供应商评估。
这些分值是采购评估维度示例，不代表真实客户评分、具体国家买家反馈或实时询盘。
Superdisintegrants (e.g., crospovidone) provide faster disintegration at lower concentrations (1-5% w/w) through superior swelling or wicking, while traditional disintegrants (e.g., starch) require higher concentrations (5-15% w/w) and work primarily through swelling.
Excessive disintegrant (>10% w/w) can reduce tablet hardness and increase friability, while insufficient amounts (<1% w/w) may prolong disintegration. Optimal concentration balances disintegration time with mechanical strength.
Yes, some disintegrants may interact with APIs through moisture absorption or chemical incompatibility. Proper selection and moisture-controlled environments are critical for stability.
CNFX 是开放目录，不是交易平台或采购代理。工厂资料和表单用于帮助你准备直接沟通。
CNFX 制造商资料、技术分类、公开产品信息和持续合理性检查。
说明目标数量、应用场景、交期和关键技术要求，用于准备 RFQ 或供应商评估。